Alnylam Pharmaceuticals
A biopharmaceutical company focusing on the discovery, development, and commercialization of RNAi therapeutics for treating rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS) diseases.
Key facts
| CAGE Code | 45SR1 |
|---|---|
| Legal Name | Alnylam Pharmaceuticals, Inc. |
| Company Operating Status | Active |
| Full Address | 675 West Kendall St Cambridge, MA 02142 |
| Legal Entity Identifier | 529900S3ZI14OWRJII50 |
| Previous Name | ALNYLAM PHARMACEUTICALS INC |
| Stock Symbol | ALNY |
| Ticker Symbol | ALNY |
| Wellfound ID | alnylam-pharmaceuticals |
| Wikidata ID | Q16974682 |
Contact details
Email and phone for Alnylam Pharmaceuticals are available to signed-in members of CliffBio.
Sign in to view